ATE402720T1 - Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik - Google Patents

Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Info

Publication number
ATE402720T1
ATE402720T1 AT03772392T AT03772392T ATE402720T1 AT E402720 T1 ATE402720 T1 AT E402720T1 AT 03772392 T AT03772392 T AT 03772392T AT 03772392 T AT03772392 T AT 03772392T AT E402720 T1 ATE402720 T1 AT E402720T1
Authority
AT
Austria
Prior art keywords
technetium
aza
diaminedioxime
conjugates
complexes
Prior art date
Application number
AT03772392T
Other languages
English (en)
Inventor
Georg Brauers
Gillian Farrar
David Jonathan Barnett
Harry John Wadsworth
Joanne Sarah Lewis
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Application granted granted Critical
Publication of ATE402720T1 publication Critical patent/ATE402720T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT03772392T 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik ATE402720T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions

Publications (1)

Publication Number Publication Date
ATE402720T1 true ATE402720T1 (de) 2008-08-15

Family

ID=9946533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03772392T ATE402720T1 (de) 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Country Status (16)

Country Link
EP (1) EP1553986B1 (de)
JP (1) JP2006508084A (de)
KR (1) KR20050070080A (de)
CN (1) CN1708322A (de)
AT (1) ATE402720T1 (de)
AU (1) AU2003279444A1 (de)
BR (1) BR0315578A (de)
CA (1) CA2501684A1 (de)
DE (1) DE60322562D1 (de)
ES (1) ES2309361T3 (de)
GB (1) GB0224799D0 (de)
MX (1) MXPA05004418A (de)
NO (1) NO20051811L (de)
RU (1) RU2005110960A (de)
WO (1) WO2004037297A1 (de)
ZA (1) ZA200502835B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
GB0520527D0 (en) * 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
GB0614337D0 (en) * 2006-07-19 2006-08-30 Acal Energy Ltd Fuel Cells
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2804509T3 (es) * 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
BR112013015580A2 (pt) * 2010-12-21 2016-10-04 Ge Healthcare Ltd método de radioestabilização
US9175044B2 (en) * 2010-12-22 2015-11-03 Tfchem Derivatives of glyco-CF2-serine and glyco-CF2-threonine
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
CN112830940B (zh) * 2020-09-07 2022-03-01 中国科学院宁波材料技术与工程研究所 2,5-呋喃二甲醛肟金属络合物及其制备方法、及在抗菌除霉消毒剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102154A3 (en) * 1998-05-15 2009-01-28 Ge Healthcare Ltd Labelled glutamine and lysine analogues
KR100866666B1 (ko) * 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates

Also Published As

Publication number Publication date
MXPA05004418A (es) 2005-11-23
NO20051811L (no) 2005-06-27
CN1708322A (zh) 2005-12-14
ZA200502835B (en) 2006-03-29
RU2005110960A (ru) 2005-11-20
CA2501684A1 (en) 2004-05-06
AU2003279444A1 (en) 2004-05-13
EP1553986B1 (de) 2008-07-30
GB0224799D0 (en) 2002-12-04
WO2004037297A1 (en) 2004-05-06
EP1553986A1 (de) 2005-07-20
DE60322562D1 (de) 2008-09-11
KR20050070080A (ko) 2005-07-05
ES2309361T3 (es) 2008-12-16
NO20051811D0 (no) 2005-04-14
JP2006508084A (ja) 2006-03-09
BR0315578A (pt) 2005-10-25

Similar Documents

Publication Publication Date Title
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
Liu et al. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands
Liu et al. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands
Schibli et al. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of 99mTc (I)− tricarbonyl complexes: a hint for the future functionalization of biomolecules
Moerlein et al. The chemistry of gallium and indium as related to radiopharmaceutical production
NO20053754D0 (no) Improved radiometal complex compositions.
DE60322562D1 (de) Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
Pirmettis et al. Synthesis and characterization of oxotechnetium (V) mixed-ligand complexes containing a tridentate N-substituted bis (2-mercaptoethyl) amine and a monodentate thiol
WO2007042781A3 (en) Automated method for preparing technetium complexes
IL175667A (en) Imaging agent which comrises a synthetic caspase-3 inhibitor labeled with an imaging moiety, a radiopharmaceutical composition comprising the same, a kit for the preparation of said composition and a method of diagnosis based thereon
ATE556722T1 (de) Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs
Nock et al. Novel six-coordinate oxorhenium “3+ 2” mixed-ligand complexes carrying the SNS/PO donor atom set: synthesis and characterization
Liu et al. Preparation and properties of 99mTc (CO) 3+-labeled N, N-bis (2-pyridylmethyl)-4-aminobutyric acid
Yang et al. Synthesis and characterization of a novel macrocyclic chelator with 3-hydroxy-4-pyrone chelating arms and its complexes with medicinally important metals
BRPI0518636B8 (pt) “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc"
JP2004524323A5 (de)
Schiller et al. Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P (‘4+ 1') Coordination: Relation of Structure with Antioxidation Stability
Purohit et al. Phosphine-containing HYNIC derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules
DE69723242D1 (de) Ternäre radiopharmazeutische komplexe
Purohit et al. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules
Thipyapong et al. Insight into technetium amidoxime complex: oxo technetium (V) complex of N-substituted benzamidoxime as new basic structure for molecular imaging
NO20055334L (no) Bifunksjonelle tridentate pyrazolylinneholdende ligander for RE og TC trikarbonylkomplekser
GB0421987D0 (en) Novel technetium and rhenium complexes
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
US20020082398A1 (en) Cores for technetium radiopharmaceuticals

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties